These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3050540)

  • 1. Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound.
    Hricak H
    NCI Monogr; 1988; (7):31-5. PubMed ID: 3050540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging modalities for prostate cancer.
    Fütterer JJ; Barentsz J; Heijmijnk ST
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):923-37. PubMed ID: 19589032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Staging and tissue characterization of prostate carcinoma: role of endorectal MR imaging and MR spectroscopy].
    Sugimura K
    Hinyokika Kiyo; 2000 Nov; 46(11):855-9. PubMed ID: 11193312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-ray computed tomography, MRI and transrectal echography of cancer of the prostate].
    Laval-Jeantet M; Tobolski F; Le Duc A; Teillac P
    Pathol Biol (Paris); 1989 Feb; 37(2):107-8. PubMed ID: 2652053
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prostatic carcinoma: current status of diagnostic imaging].
    Bloch BN; Helbich T; Heinz-Peer G
    Wien Med Wochenschr Suppl; 2002; (113):89-91. PubMed ID: 12621851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of localized prostate cancer: a clinical-pathologic correlation.
    Mukamel E; de Kernion JB; Hannah J; Barbaric Z
    J Urol (Paris); 1988; 94(8):381-8. PubMed ID: 3241091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of prostate capsular invasion by pelvic magnetic resonance imaging and serum level of prostate specific antigen].
    Mikata K; Uemura H; Fujinami K; Ohuchi H; Miyoshi Y; Ohta J; Osada Y; Jinza S; Kubota Y; Hosaka M; Nakatani I; Takebayashi S
    Hinyokika Kiyo; 2001 Jun; 47(6):385-8. PubMed ID: 11496393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
    Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
    Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate and lymph node proton magnetic resonance (MR) spectroscopic imaging with external array coils at 3 T to detect recurrent prostate cancer after radiation therapy.
    Heijmink SW; Scheenen TW; Fütterer JJ; Klomp DW; Heesakkers RA; Hulsbergen-van de Kaa CA; van Lin EN; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Jun; 42(6):420-7. PubMed ID: 17507814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.
    Martorana G; Schiavina R; Corti B; Farsad M; Salizzoni E; Brunocilla E; Bertaccini A; Manferrari F; Castellucci P; Fanti S; Canini R; Grigioni WF; D'Errico Grigioni A
    J Urol; 2006 Sep; 176(3):954-60; discussion 960. PubMed ID: 16890665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance (MR) imaging of prostatic tumours, a comparison with X-ray CT and transrectal sonography (TRS).
    Bockisch A; Jäger N; Biersack HJ; Vahlensieck W; Hünermann B; Schmitz HG; Knopp R; Christ F; Winkler C
    Eur J Radiol; 1988 Feb; 8(1):54-9. PubMed ID: 2451610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.
    Jones GW; Mettlin C; Murphy GP; Guinan P; Herr HW; Hussey DH; Chmiel JS; Fremgen AM; Clive RE; Zuber-Ocwieja KE
    J Am Coll Surg; 1995 May; 180(5):545-54. PubMed ID: 7538405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate carcinoma presentation, diagnosis, and staging: an update form the National Cancer Data Base.
    Miller DC; Hafez KS; Stewart A; Montie JE; Wei JT
    Cancer; 2003 Sep; 98(6):1169-78. PubMed ID: 12973840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of incidentally detected prostate cancer: role of repeat resection, prostate-specific antigen, needle biopsy, and imaging.
    Griebling TL; Williams RD
    Semin Urol Oncol; 1996 Aug; 14(3):156-64. PubMed ID: 8865478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node staging in potentially curable prostatic carcinoma.
    Okada K; Yoshida O; Paulson DF; Rutishauser G
    Prog Clin Biol Res; 1988; 269():211-25. PubMed ID: 3293061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.